Pasar al contenido principal

PAPEL DEL TRANSPORTADOR ABCG2 Y SUS POLIMORFISMOS EN LA EXCRECION DE AGENTES ANTIPARASITARIOS Y PESTICIDAS EN LECHE DE RUMIANTES

RTI2018-100903-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

ABCG2 transporter plays a key role in the biodistribution of melatonin and its main metabolites

  • Álvarez Fernández, Laura
  • Gomez‐Gomez, Alex
  • Haro, Noemí
  • García‐Lino, Alba M.
  • Álvarez de Felipe, Ana Isabel
  • Pozo, Oscar J.
  • Merino Peláez, Gracia
[EN] The ATP-binding cassette G2 (ABCG2) is an efflux transporter expressed in the apical membrane of cells from a large number of tissues, directly affecting bioavailability, tissue accumulation, and secretion into milk of both xenobiotics and endogenous compounds. The aim of this work was to characterize the role of ABCG2 in the systemic distribution and secretion into milk of melatonin and its main metabolites, 6-hydroxymelatonin, and 6-sulfatoxymelatonin. For this purpose, we first showed that these three molecules are transported by this transporter using in vitro transepithelial assays with MDCK-II polarized cells transduced with different species variants of ABCG2. Second, we tested the in vivo effect of murine Abcg2 in the systemic distribution of melatonin and its metabolites using wild-type and Abcg2−/− mice. Our results show that after oral administration of melatonin, the plasma concentration of melatonin metabolites in Abcg2−/− mice was between 1.5 and 6-fold higher compared to the wild-type mice. We also evaluated in these animals differences in tissue accumulation of melatonin metabolites. The most relevant differences between both types of mice were found for small intestine and kidney (>sixfold increase for 6-sulfatoxymelatonin in Abcg2−/− mice). Finally, melatonin secretion into milk was also affected by the murine Abcg2 transporter, with a twofold higher milk concentration in wild-type compared with Abcg2−/− lactating female mice. In addition, melatonin metabolites showed a higher milk-to-plasma ratio in wild-type mice. Overall, our results show that the ABCG2 transporter plays a critical role in the biodistribution of melatonin and its main metabolites, thereby potentially affecting their biological and therapeutic activity., SI, Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

In vitro interaction of the pesticides flupyradifurone, bupirimate and its metabolite ethirimol with the ATP-binding cassette transporter G2 (ABCG2)

  • Ben Halima, Nada
  • Álvarez Fernández, Laura
  • Blanco Paniagua, Esther
  • Abid-Essefi, Salwa
  • Guedri, Yosra
  • Merino Peláez, Gracia
[EN] ABCG2 is an ATP-binding cassette efflux transporter that is expressed in absorptive and excretory organs such as liver, intestine, kidney, brain and testis where it plays a crucial physiological and toxicological role in protecting cells against xenobiotics, affecting pharmacokinetics of its substrates. In addition, the induction of ABCG2 expression in mammary gland during lactation is related to active secretion of many toxicants into milk. In this study, the in vitro interactions between ABCG2 and three pesticides flupyradifurone, bupirimate and its metabolite ethirimol were investigated to check whether these compounds are substrates and/or inhibitors of this transporter. Using in vitro transepithelial assays with cells transduced with murine, ovine and human ABCG2, we showed that ethirimol and flupyradifurone were transported efficiently by murine Abcg2 and ovine ABCG2 but not by human ABCG2. Bupirimate was not found to be an in vitro substrate of ABCG2 transporter. Accumulation assays using mitoxantrone in transduced MDCK-II cells suggest that none of the tested pesticides were efficient ABCG2 inhibitors, at least in our experimental conditions. Our studies disclose that ethirimol and flupyradifurone are in vitro substrates of murine and ovine ABCG2, opening the possibility of a potential relevance of ABCG2 in the toxicokinetics of these pesticides., SI
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Evaluación de la interacción de antiinflamatorios y antiparasitarios con el transportador ABCG2 : efecto en la seguridad de la leche, Evaluation of the interaction of anti-inflammatory and antiparasitic drugs with the ABCG2 transporter : effects on milk safety

  • Blanco Paniagua, Esther
236 p., [ES] El transportador de membrana ABCG2 es una proteína transportadora perteneciente a la subfamilia G de los transportadores ABC (ATP-Binding Cassette). Se expresa en la membrana apical de células pertenecientes a órganos de interés farmacocinético como el hígado, riñón e intestino, así como en las principales barreras protectoras: hematoencefálica, hematotesticular y fetoplacentaria (Vlaming et al., 2009; Stacy et al., 2013), actuando como una bomba que expulsa compuestos fuera de la célula (Khunweeraphong et al., 2019). Una de las características fundamentales de ABCG2 reside en su capacidad para interaccionar con una amplia variedad de sustancias de distinta naturaleza, como compuestos endógenos, naturales, fármacos y compuestos tóxicos (Mo y Zhang, 2012; Mao y Unadkat, 2015; Safar et al., 2019; Zattoni et al., 2022), los cuales pueden interaccionar como sustratos, inhibidores o ambos. Debido a su distribución y capacidad de interacción con diferentes compuestos, este transportador juega un papel fundamental en la protección del organismo frente a compuestos tóxicos. Asimismo, participa en los procesos de absorción, distribución y eliminación de fármacos, limitando su absorción intestinal y favoreciendo su eliminación y, por lo tanto, afectando a su disponibilidad, eficacia y toxicidad (Vlaming et al., 2009; Basseville et al., 2016). Además, ABCG2 está involucrado en el desarrollo de resistencias a fármacos antitumorales, lo cual agrava el pronóstico del cáncer al limitar la acumulación intracelular de estos fármacos en las células tumorales (Chen et al., 2016)., Ministerio de Economía y Competitividad del Gobierno de España, Ministerio de Ciencia, Innovación y Universidades. Agencia Estatal de Investigación
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Coadministration of ivermectin and abamectin affects milk pharmacokinetics of the antiparasitic clorsulon in Assaf sheep

  • Blanco Paniagua, Esther
  • Álvarez Fernández, Laura
  • Millán García, Alicia
  • Rivas Campoamor, Guillermo
  • Álvarez de Felipe, Ana Isabel
  • Merino Peláez, Gracia
[EN] In veterinary field, drug exposure during milk production in dairy cattle is considered a major health problem which concerns dairy consumers. The induced expression of the ABC transporter G2 (ABCG2) in the mammary gland during lactation plays a significant role in the active secretion of many compounds into milk. The main objective of this study was to determine the involvement of ABCG2 in the secretion into milk of the antiparasitic clorsulon in sheep as well as the possible effect of the coadministration of model ABCG2 inhibitors such as macrocyclic lactones on this process. Cells transduced with the ovine variant of ABCG2 were used to carry out in vitro transepithelial transport assays in which we showed that clorsulon is a substrate of the ovine transporter. In addition, ivermectin and abamectin significantly inhibited clorsulon transport mediated by ovine ABCG2. In vivo interactions were studied in Assaf sheep after coadministration of clorsulon (in DMSO, 2 mg/kg, s.c.) with ivermectin (Ivomec®, 0.2 mg/kg, s.c.) or abamectin (in DMSO, 0.2 mg/kg, s.c.). After ivermectin and abamectin treatment, no relevant statistically significant differences in plasma levels of clorsulon were reported between the experimental groups since there were no differences in the area under the plasma concentration-curve (AUC) between clorsulon treatment alone and coadministration with macrocyclic lactones. With regard to milk, total amount of clorsulon, as percentage of dose excreted, did not show statistically significant differences when macrocyclic lactones were coadministered. However, the AUC for clorsulon significantly decreased (p < 0.05) after coadministration with ivermectin (15.15 ± 3.17 μg h/mL) and abamectin (15.30 ± 3.25 μg h/mL) compared to control group (20.73 ± 4.97 μg h/mL). Moreover, milk parameters such as half- life (T1/2) and mean residence time (MRT) were significantly lower (p < 0.05) after coadministration of macrocyclic lactones. This research shows that the milk pharmacokinetics of clorsulon is affected by the coadministration of ABCG2 inhibitors, reducing drug persistence in milk., SI
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Ivermectin inhibits ovine ABCG2-mediated in vitro transport of meloxicam and reduces its secretion into milk in sheep

  • Blanco Paniagua, Esther
  • García Lino, Alba María
  • Álvarez Fernández, Laura
  • Álvarez de Felipe, Ana Isabel
  • Merino Peláez, Gracia
[EN] The ATP-binding cassette transporter G2 (ABCG2) is an efflux protein involved in the bioavailability and secretion into milk of several compounds including anti inflammatory drugs. The aim of this work was to determine the effect in sheep of an ABCG2 inhibitor, such as the macrocyclic lactone ivermectin, on the secretion into milk of meloxicam, a non-steroidal anti-inflammatory drug widely used in veterinary medicine, and recently reported as an ABCG2 substrate. In vitro meloxicam transport assays in ovine ABCG2-transduced cells have shown that ivermectin is an efficient inhibitor of in vitro transport of meloxicam mediated by ovine ABCG2, with a 75% inhibition in the transport ratio (24.85 ± 4.62 in controls vs 6.31 ± 1.37 in presence of ivermectin). In addition, the role of ovine ABCG2 in secretion into milk of meloxicam was corroborated using Assaf lactating sheep coadministered with ivermectin. Animals were administered subcutaneously with meloxicam (0.5 mg/kg) with or without ivermectin (0.2 mg/kg). No difference in plasma pharmacokinetic parameters was found between treatments. In the case of milk, a significant reduction in the area under concentration-time curve (AUC) (3.92 ± 0.66 vs 2.26 ± 1.52 vs μg·h/mL) and the AUC milk-to-plasma ratio (0.17 ± 0.03 vs 0.09 ± 0.06) was reported for ivermectin-treated animals compared to controls., SI, This work was supported by the research projects AGL2015-65626-R (MCIN/AEI/10.13039/501100011033/FEDER” Una manera de hacer Europa”) and RTI2018-100903-B-I00 (MCIN/AEI/10.13039/501100011033/FEDER” Una manera de hacer Europa”); and by the predoctoral grants (FPU18/01559 grant to EBP, FPU19/04169 grant to LAF) from the Spanish Ministry of Education, Culture and Sport and BES-2016-077235 grant to AMGL (MCIN/AEI/10.13039/501100011033 y FSE ”El FSE invierte en tu futuro”). We are grateful to Prof. James McCue for assistance with language editing.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

The ABCG2 protein in vitro transports the xenobiotic thiabendazole and increases the appearance of its residues in milk

  • Álvarez Fernández, Laura
  • Blanco Paniagua, Esther
  • Millán García, Alicia
  • Velasco Díez, Miriam
  • Álvarez de Felipe, Ana Isabel
  • Merino Peláez, Gracia
[EN] Thiabendazole (2–(4–thiazolyl)benzimidazole, TBZ) is a broad–spectrum anthelmintic widely used in humans and cattle. It is also used as post–harvest agricultural fungicide, thus preserving crop quality and marketability (Hajikhani et al., 2024). Adverse effects after TBZ exposure including endocrine, nephrogenic, hepatogenic, teratogenic and neurological effects have been reported in mammals (Ekman et al., 2014). Etiological factors behind TBZ toxicity remain ambiguous; however, it has been hypothesized that it may be due to its bioactivation to 5OH–TBZ by the cytochrome P450 1A2 (CYP1A2) (Coulet et al., 1998a; Jamieson et al., 2011) (Fig. 1). Therefore, National and International Food Safety Authorities have established regulations for the usage of TBZ on food products setting maximum residue limits (MRLs) for the sum of TBZ and its metabolites in both agricultural and animal products ranging from 0.01 to 7 mg/kg depending on the product (European Food Safety Authority (EFSA) et al., 2021; U.S. Food and Drug Administration (FDA), 2021). Unfortunately, MRLs derived from pesticide use are equal to or higher than veterinary MRLs for all commodities, and the possible aggregated exposure from TBZ residues has not been studied, making it impossible to rule out an overexposure to TBZ through the food chain., SI, Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

ABCG2 Transports the Flukicide Nitroxynil and Affects Its Biodistribution and Secretion into Milk

  • Álvarez Fernández, Laura
  • Blanco Paniagua, Esther
  • Merino Peláez, Gracia
[EN]The ABCG2 transporter plays a key role in pharmacological and toxicological processes, affecting bioavailability, tissue accumulation and milk secretion of its substrates. This protein is expressed in several biological barriers acting as a protective mechanism against xenobiotic exposure by pumping out a broad range of compounds. However, its induced expression during lactation in alveolar cells of mammary gland represents a relevant route for active transport of unwanted chemicals into milk. This work aimed to characterize the involvement of ABCG2 in systemic exposure and milk secretion of the flukicide nitroxynil. Using MDCK–II cells overexpressing the transporter, we showed that nitroxynil is an in vitro substrate of different species variants of ABCG2. Moreover, using wild-type and Abcg2−/− mice, we showed that murine Abcg2 clearly affects plasma levels of nitroxynil. We also reported differences in nitroxynil accumulation in several tissues, with almost 2-fold higher concentration in kidney, small intestine and testis of Abcg2−/− mice. Finally, we proved that nitroxynil secretion into milk was also affected by Abcg2, with a 1.9-fold higher milk concentration in wild-type compared with Abcg2−/− mice. We conclude that ABCG2 significantly impacts nitroxynil biodistribution by regulating its passage across biological barriers., SI, This research was funded by the research projects RTI2018–100903–B–I00 and PID2021–125660OB–100 (MCIN/AEI/10.13039/501100011033/FEDER “Una manera de hacer Europa”) and by the predoctoral grants from Spanish Ministry of Education, Culture and Sport (FPU18/01559 grant to EBP and FPU19/04169 grant to LAF)
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Papel dual del transportador ABCG2 en la secreción a leche de compuestos endógenos y fármacos con actividad antiparasitaria, Dual role of the ABCG2 transporter in the secretion into milk of endogenous compounds and drugs with antiparasitic activity

  • Álvarez Fernández, Laura
197 p., [ES] El transportador ATP-Binding Cassette G2 (ABCG2) es una proteína integral de membrana perteneciente a la subfamilia G de los transportadores ATP-Binding Cassette (ABC) que funciona como una bomba de eflujo poliespecífica capaz de exportar un amplio espectro de sustancias de diversa naturaleza molecular (compuestos endógenos, naturales, fármacos y otros xenobióticos) hacia el exterior de las células (Eckenstaler y Benndorf, 2020). Esta proteína se expresa en la membrana apical de las células de numerosos tejidos y órganos de interés farmacológico y toxicológico implicados en la biodisponibilidad de sus sustratos tales como el intestino, el hígado o el riñón, así como en las principales barreras fisiológicas (hematoencefálica, hematotesticular y fetoplacentaria) (Vlaming et al., 2009; Stacy et al., 2013), regulando la entrada de sustancias no deseadas, como ciertas toxinas, al interior del organismo. Además, es uno de los principales responsables de la ampliamente conocida resistencia frente a múltiples fármacos (Duvivier et al., 2024). En contraposición al papel protector previamente descrito, ABCG2 también participa en el paso a leche de numerosas moléculas incluyendo algunos fármacos de uso veterinario, como los antiparasitarios, los cuales representan el sector más importante de la industria farmacéutica animal (Blanco-Paniagua et al., 2022a). Asimismo, participa en la secreción de algunas vitaminas, como la riboflavina y el ácido fólico, y de compuestos estrogénicos, como los fitoestrógenos, a la leche (van Herwaarden et al., 2007; García Mateos et al., 2017)., [EN] Considering that milk is a crucial food source for the optimal growth and development of mammals, as well as a vital component of human diet worldwide, understanding any factor that could affect the transport of xenobiotics (such as drugs) or natural substances (such as vitamins and hormones) to milk is a priority. This knowledge is essential to predict and mitigate potential unexpected contamination of dairy products and to produce safe, high-quality milk with improved nutritional value. In dairy animals, the use of antiparasitic agents is a widespread practice for treatment and prevention of parasitic diseases (Lanusse et al., 2018). However, despite its undoubted benefits, the potential risk of unwanted elimination of pharmacological residues in food products intended for human consumption, such as milk, is a major concern for food safety and public health (Virkel et al., 2018). Conversely, milk transfer of beneficial endogenous compounds naturally synthesized by the animal, such as vitamins, could improve the nutritional quality of dairy products for consumers (García-Lino et al., 2019). In this context, and due to its relevant role in the secretion of its substrates into milk, as well as its influence on their plasma and tissue profile, the study of the interaction of the ABCG2 transporter with compounds present in milk both naturally and after exogenous administration is of particular relevance. Interestingly, the physiological role of this protein in the mammary gland remains slightly paradoxical. ABCG2 is known to facilitate the transfer of essential nutrients and vitamins, such as folic acid and riboflavin, to newborn. However, it is also responsible for the secretion of toxic substances, including certain drugs, into milk, which could pose risks to both breast-fed infants and consumers of dairy products (Imperiale & Lanusse, 2021). Given this dual role, the primary goal of our research group is to understand why a protein that apparently protects the body from xenobiotic exposure can also facilitate the accumulation of toxic substrates in milk, a function that seems difficult to reconcile with the need to protect the offspring. Considering the aforementioned, this PhD Thesis aimed to explore the involvement of ABCG2 in the in vitro transport, plasma and tissue bioavailability, and milk secretion of the endogenous compound melatonin, and the antiparasitic drugs thiabendazole and nitroxynil. To achieve this goal, a common methodology was employed. First, in vitro transepithelial transport assays were conducted using Madin-Darby Canine Kidney II (MDCK-II) cells and its subclones transduced with the murine, ovine, bovine, and human isoforms of the ABCG2 transporter to evaluate its role in the active transport of these molecules. Second, in vivo studies were performed using male wild-type and Abcg2(–/–) mice to assess the effect of this transporter on plasma bioavailability and tissue distribution of these compounds. Third, lactating mice were used to examine whether the Abcg2 transporter influences their milk secretion. Finally, metabolomic analyses were carried out to determine the impact of ABCG2 on milk metabolome.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

ABCG2 transporter plays a key role in the biodistribution of melatonin and its main metabolites

  • Álvarez-Fernández, Laura
  • Gómez-Gómez, Àlex
  • Haro, Noemí
  • García-Lino, Alba M.
  • Álvarez, Ana I.
  • Pozo Mendoza, Óscar J., 1975-
  • Merino, Gracia
The ATP-binding cassette G2 (ABCG2) is an efflux transporter expressed in the apical membrane of cells from a large number of tissues, directly affecting bioavailability, tissue accumulation, and secretion into milk of both xenobiotics and endogenous compounds. The aim of this work was to characterize the role of ABCG2 in the systemic distribution and secretion into milk of melatonin and its main metabolites, 6-hydroxymelatonin, and 6-sulfatoxymelatonin. For this purpose, we first showed that these three molecules are transported by this transporter using in vitro transepithelial assays with MDCK-II polarized cells transduced with different species variants of ABCG2. Second, we tested the in vivo effect of murine Abcg2 in the systemic distribution of melatonin and its metabolites using wild-type and Abcg2-/- mice. Our results show that after oral administration of melatonin, the plasma concentration of melatonin metabolites in Abcg2-/- mice was between 1.5 and 6-fold higher compared to the wild-type mice. We also evaluated in these animals differences in tissue accumulation of melatonin metabolites. The most relevant differences between both types of mice were found for small intestine and kidney (>sixfold increase for 6-sulfatoxymelatonin in Abcg2-/- mice). Finally, melatonin secretion into milk was also affected by the murine Abcg2 transporter, with a twofold higher milk concentration in wild-type compared with Abcg2-/- lactating female mice. In addition, melatonin metabolites showed a higher milk-to-plasma ratio in wild-type mice. Overall, our results show that the ABCG2 transporter plays a critical role in the biodistribution of melatonin and its main metabolites, thereby potentially affecting their biological and therapeutic activity., The authors thank Dr. A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) who provided parental MDCK-II cells and its murine Abcg2 and human ABCG2-transduced subclones, as well as Abcg2 knockout mice. We are grateful to Prof. James McCue for assistance with language editing. This work was supported by the research project RTI2018-100903-B-I00 and PID2021-125660OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER “Una manera de hacer Europa”) and by predoctoral grants (FPU19/04169 grant to LAF) from the Spanish Ministry of Education, Culture and Sport.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

ABCG2 transporter plays a key role in the biodistribution of melatonin and its main metabolites

  • Álvarez-Fernández, Laura
  • Gómez-Gómez, Àlex
  • Haro, Noemí
  • García-Lino, Alba M.
  • Álvarez, Ana I.
  • Pozo Mendoza, Óscar J., 1975-
  • Merino, Gracia
The ATP-binding cassette G2 (ABCG2) is an efflux transporter expressed in the apical membrane of cells from a large number of tissues, directly affecting bioavailability, tissue accumulation, and secretion into milk of both xenobiotics and endogenous compounds. The aim of this work was to characterize the role of ABCG2 in the systemic distribution and secretion into milk of melatonin and its main metabolites, 6-hydroxymelatonin, and 6-sulfatoxymelatonin. For this purpose, we first showed that these three molecules are transported by this transporter using in vitro transepithelial assays with MDCK-II polarized cells transduced with different species variants of ABCG2. Second, we tested the in vivo effect of murine Abcg2 in the systemic distribution of melatonin and its metabolites using wild-type and Abcg2-/- mice. Our results show that after oral administration of melatonin, the plasma concentration of melatonin metabolites in Abcg2-/- mice was between 1.5 and 6-fold higher compared to the wild-type mice. We also evaluated in these animals differences in tissue accumulation of melatonin metabolites. The most relevant differences between both types of mice were found for small intestine and kidney (>sixfold increase for 6-sulfatoxymelatonin in Abcg2-/- mice). Finally, melatonin secretion into milk was also affected by the murine Abcg2 transporter, with a twofold higher milk concentration in wild-type compared with Abcg2-/- lactating female mice. In addition, melatonin metabolites showed a higher milk-to-plasma ratio in wild-type mice. Overall, our results show that the ABCG2 transporter plays a critical role in the biodistribution of melatonin and its main metabolites, thereby potentially affecting their biological and therapeutic activity., The authors thank Dr. A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) who provided parental MDCK-II cells and its murine Abcg2 and human ABCG2-transduced subclones, as well as Abcg2 knockout mice. We are grateful to Prof. James McCue for assistance with language editing. This work was supported by the research project RTI2018-100903-B-I00 and PID2021-125660OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER “Una manera de hacer Europa”) and by predoctoral grants (FPU19/04169 grant to LAF) from the Spanish Ministry of Education, Culture and Sport.